These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
362 related articles for article (PubMed ID: 16965204)
1. Attenuation of antipsychotic-induced weight gain with early behavioral intervention in drug-naive first-episode psychosis patients: A randomized controlled trial. Alvarez-Jiménez M; González-Blanch C; Vázquez-Barquero JL; Pérez-Iglesias R; Martínez-García O; Pérez-Pardal T; Ramírez-Bonilla ML; Crespo-Facorro B J Clin Psychiatry; 2006 Aug; 67(8):1253-60. PubMed ID: 16965204 [TBL] [Abstract][Full Text] [Related]
2. Metformin addition attenuates olanzapine-induced weight gain in drug-naive first-episode schizophrenia patients: a double-blind, placebo-controlled study. Wu RR; Zhao JP; Guo XF; He YQ; Fang MS; Guo WB; Chen JD; Li LH Am J Psychiatry; 2008 Mar; 165(3):352-8. PubMed ID: 18245179 [TBL] [Abstract][Full Text] [Related]
3. A 12-week randomized clinical trial to evaluate metabolic changes in drug-naive, first-episode psychosis patients treated with haloperidol, olanzapine, or risperidone. Perez-Iglesias R; Crespo-Facorro B; Amado JA; Garcia-Unzueta MT; Ramirez-Bonilla ML; Gonzalez-Blanch C; Martinez-Garcia O; Vazquez-Barquero JL J Clin Psychiatry; 2007 Nov; 68(11):1733-40. PubMed ID: 18052567 [TBL] [Abstract][Full Text] [Related]
4. A practical clinical trial comparing haloperidol, risperidone, and olanzapine for the acute treatment of first-episode nonaffective psychosis. Crespo-Facorro B; Pérez-Iglesias R; Ramirez-Bonilla M; Martínez-García O; Llorca J; Luis Vázquez-Barquero J J Clin Psychiatry; 2006 Oct; 67(10):1511-21. PubMed ID: 17107241 [TBL] [Abstract][Full Text] [Related]
5. Weight gain in newly diagnosed first-episode psychosis patients and healthy comparisons: one-year analysis. Strassnig M; Miewald J; Keshavan M; Ganguli R Schizophr Res; 2007 Jul; 93(1-3):90-8. PubMed ID: 17478082 [TBL] [Abstract][Full Text] [Related]
6. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies. Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596 [TBL] [Abstract][Full Text] [Related]
7. Predictors of antipsychotic-induced weight gain in first-episode psychosis: conclusions from a randomized, double-blind, controlled prospective study of olanzapine, risperidone, and haloperidol. Saddichha S; Ameen S; Akhtar S J Clin Psychopharmacol; 2008 Feb; 28(1):27-31. PubMed ID: 18204337 [TBL] [Abstract][Full Text] [Related]
8. Risperidone and haloperidol in first-episode psychosis: a long-term randomized trial. Schooler N; Rabinowitz J; Davidson M; Emsley R; Harvey PD; Kopala L; McGorry PD; Van Hove I; Eerdekens M; Swyzen W; De Smedt G; Am J Psychiatry; 2005 May; 162(5):947-53. PubMed ID: 15863797 [TBL] [Abstract][Full Text] [Related]
9. Weight management program for treatment-emergent weight gain in olanzapine-treated patients with schizophrenia or schizoaffective disorder: A 12-week randomized controlled clinical trial. Kwon JS; Choi JS; Bahk WM; Yoon Kim C; Hyung Kim C; Chul Shin Y; Park BJ; Geun Oh C J Clin Psychiatry; 2006 Apr; 67(4):547-53. PubMed ID: 16669719 [TBL] [Abstract][Full Text] [Related]
10. Early Stabilization of Weight Changes Following Treatment With Olanzapine, Risperidone, and Aripiprazole: A 12-Month Naturalistic Study of First Episode Psychosis. Mustafa S; Joober R; Iyer S; Shah J; Lepage M; Malla A J Clin Psychiatry; 2019 Aug; 80(5):. PubMed ID: 31509359 [TBL] [Abstract][Full Text] [Related]
11. Management of antipsychotic-induced weight gain: prospective naturalistic study of the effectiveness of a supervised exercise programme. Poulin MJ; Chaput JP; Simard V; Vincent P; Bernier J; Gauthier Y; Lanctôt G; Saindon J; Vincent A; Gagnon S; Tremblay A Aust N Z J Psychiatry; 2007 Dec; 41(12):980-9. PubMed ID: 17999270 [TBL] [Abstract][Full Text] [Related]
12. Prevention of antipsychotic-induced weight gain with early behavioural intervention in first-episode psychosis: 2-year results of a randomized controlled trial. Alvarez-Jiménez M; Martínez-García O; Pérez-Iglesias R; Ramírez ML; Vázquez-Barquero JL; Crespo-Facorro B Schizophr Res; 2010 Jan; 116(1):16-9. PubMed ID: 19896336 [TBL] [Abstract][Full Text] [Related]
13. Relapse prevention and remission attainment in first-episode non-affective psychosis. A randomized, controlled 1-year follow-up comparison of haloperidol, risperidone and olanzapine. Crespo-Facorro B; Pérez-Iglesias R; Mata I; Caseiro O; Martínez-Garcia O; Pardo G; Ramirez-Bonilla M; Pelayo-Terán JM; Vázquez-Barquero JL J Psychiatr Res; 2011 Jun; 45(6):763-9. PubMed ID: 21106207 [TBL] [Abstract][Full Text] [Related]
14. Effect of olanzapine, risperidone, and haloperidol treatment on weight and body mass index in first-episode schizophrenia patients in India: a randomized, double-blind, controlled, prospective study. Saddichha S; Manjunatha N; Ameen S; Akhtar S J Clin Psychiatry; 2007 Nov; 68(11):1793-8. PubMed ID: 18052574 [TBL] [Abstract][Full Text] [Related]
15. Evaluating an individualized lifestyle and life skills intervention to prevent antipsychotic-induced weight gain in first-episode psychosis. Curtis J; Watkins A; Rosenbaum S; Teasdale S; Kalucy M; Samaras K; Ward PB Early Interv Psychiatry; 2016 Jun; 10(3):267-76. PubMed ID: 25721464 [TBL] [Abstract][Full Text] [Related]
16. Managing atypical antipsychotic-associated weight gain: 12-month data on a multimodal weight control program. Menza M; Vreeland B; Minsky S; Gara M; Radler DR; Sakowitz M J Clin Psychiatry; 2004 Apr; 65(4):471-7. PubMed ID: 15119908 [TBL] [Abstract][Full Text] [Related]
17. Weight gain and antipsychotic medication: differences between antipsychotic-free and treatment periods. Simpson MM; Goetz RR; Devlin MJ; Goetz SA; Walsh BT J Clin Psychiatry; 2001 Sep; 62(9):694-700. PubMed ID: 11681765 [TBL] [Abstract][Full Text] [Related]